Biotech M&A is MIA - TheStreet.com | M&A | Scoop.it
The Guardian
Biotech M&A is MIA
TheStreet.com
What strikes me most about this sudden surge in healthcare M&A -- $153.6 billion so far in 2014 NOT counting the Pfizer-AstraZeneca proposal -- is the absence of biotech companies from the equation.